Medline Statistics
Total Valuation
Medline has a market cap or net worth of $55.44 billion. The enterprise value is $67.30 billion.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Medline has 1.35 billion shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 824.15M |
| Shares Outstanding | 1.35B |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 193.76M |
Valuation Ratios
The trailing PE ratio is 40.80.
| PE Ratio | 40.80 |
| Forward PE | n/a |
| PS Ratio | 18.48 |
| Forward PS | n/a |
| PB Ratio | 30.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 51.19 |
| P/OCF Ratio | 35.82 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 20.69, with an EV/FCF ratio of 66.70.
| EV / Earnings | 53.16 |
| EV / Sales | 2.45 |
| EV / EBITDA | 20.69 |
| EV / EBIT | 29.91 |
| EV / FCF | 66.70 |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.99.
| Current Ratio | 3.66 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 4.95 |
| Debt / FCF | 16.50 |
| Interest Coverage | 2.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 6.57% |
| Revenue Per Employee | $637,884 |
| Profits Per Employee | $29,442 |
| Employee Count | 43,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medline has paid $81.00 million in taxes.
| Income Tax | 81.00M |
| Effective Tax Rate | 6.01% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 26,209,753 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medline had revenue of $27.43 billion and earned $1.27 billion in profits. Earnings per share was $0.07.
| Revenue | 27.43B |
| Gross Profit | 7.46B |
| Operating Income | 2.25B |
| Pretax Income | 1.35B |
| Net Income | 1.27B |
| EBITDA | 3.25B |
| EBIT | 2.25B |
| Earnings Per Share (EPS) | $0.07 |
Full Income StatementBalance Sheet
The company has $997.00 million in cash and $16.65 billion in debt, giving a net cash position of -$15.65 billion or -$11.58 per share.
| Cash & Cash Equivalents | 997.00M |
| Total Debt | 16.65B |
| Net Cash | -15.65B |
| Net Cash Per Share | -$11.58 |
| Equity (Book Value) | 16.77B |
| Book Value Per Share | 0.96 |
| Working Capital | 6.95B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.44 billion and capital expenditures -$433.00 million, giving a free cash flow of $1.01 billion.
| Operating Cash Flow | 1.44B |
| Capital Expenditures | -433.00M |
| Free Cash Flow | 1.01B |
| FCF Per Share | $0.75 |
Full Cash Flow StatementMargins
Gross margin is 27.18%, with operating and profit margins of 8.20% and 4.62%.
| Gross Margin | 27.18% |
| Operating Margin | 8.20% |
| Pretax Margin | 4.91% |
| Profit Margin | 4.62% |
| EBITDA Margin | 11.86% |
| EBIT Margin | 8.20% |
| FCF Margin | 3.68% |
